1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd.

CAPLIPOINT.BO
Caplin Point Laboratories Ltd.IN flagBombay Stock Exchange
2,625.15
INR
+89.80
- -
199.76BMarket Cap

Total Valuation

Caplin Point Laboratories Ltd. carries a market capitalization of 199.76B, placing it among publicly traded companies globally. Its enterprise value stands at 160.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap199.76B
Enterprise Value160.89B

Valuation Ratios

Caplin Point Laboratories Ltd. trades at a trailing price-to-earnings ratio of 28.47.

PE Ratio28.47
PS Ratio8.09
PB RatioN/A
P/TBV RatioN/A
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Caplin Point Laboratories Ltd. trades at an EV/EBITDA multiple of 26.52 and an EV/FCF ratio of 27,108.40. The EV/Sales ratio of 8.09 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.52 provides insight into valuation relative to core operating earnings.

EV / Sales8.09
EV / EBITDA26.52
EV / EBIT26.52
EV / FCF27,108.40

Financial Position

Caplin Point Laboratories Ltd. maintains a current ratio of 13.03, meaning it holds 13.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.27, indicating conservative leverage, while an interest coverage ratio of 819.70 demonstrates strong ability to service its debt obligations.

Current Ratio13.03
Quick Ratio4.32
Debt / Equity0.27
Debt / EBITDAN/A
Interest Coverage819.70

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)N/A
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)1,061.44
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Caplin Point Laboratories Ltd. has paid 1.40B in income taxes, reflecting an effective tax rate of 19.80.

Income Tax1.40B
Effective Tax Rate19.80

Stock Price Statistics

Caplin Point Laboratories Ltd.'s stock has gained approximately 27.8005% over the past 52 weeks. The 50-day moving average sits at 2,125.45, while the 200-day moving average is 1,918.78.

Beta (5Y)N/A
52-Week Price Change27.8005%
50-Day Moving Average2,125.45
200-Day Moving Average1,918.78
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Caplin Point Laboratories Ltd. generated 19.89B in revenue and converted that into 5.65B in net income, yielding earnings per share of 74.26. EBITDA reached 6.07B, while operating income came in at 6.07B.

Revenue19.89B
Gross Profit12.08B
Operating Income6.07B
Pretax Income7.07B
Net Income5.65B
EBITDA6.07B
EBIT6.07B
Earnings Per Share (EPS)74.26

Margins

Caplin Point Laboratories Ltd. operates with a gross margin of 60.75, reflecting its pricing power and cost economics. The operating margin of 30.50 and net profit margin of 28.42 provide insight into operational efficiency.

Gross Margin60.75
Operating Margin30.50
Pretax Margin35.54
Profit Margin28.42
EBITDA Margin30.50

Stock Splits

Caplin Point Laboratories Ltd.'s most recent stock split took place on October 19, 2016 with a 1:5 split ratio.

Last Split Date10/19/2016
Split Ratio1:5

Scores

Caplin Point Laboratories Ltd. posts an Altman Z-Score of 56.88, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score56.88